BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$154.79
Tradestie Score
51
Market Cap
$2.41B
Analyst Upside
+36.0%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$76.45
|
$6.68B | - | 60 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$102.78
|
$6.64B | - | 60 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$124.78
|
$6.38B | - | 57 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.01
|
$6.03B | - | 54 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.57
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 57 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$211.04
|
$5.92B | - | 54 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$46.17
|
$5.80B | 18.2 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$312.57
|
$5.20B | 45.7 | 59 | Compare |
More BLTE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry